Biodegradable polymer sirolimus-eluting or durable polymer zotarolimus-eluting stents in high bleeding-risk patients with acute coronary syndrome: the BIOFLOW-DAPT randomized trial

Heart, Artery and Coronary DiseasesTherapy and Intervention

Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial

Circulation

Spaulding C, Krackhardt F, Bogaerts K, Abdelaal E, Alfonso F, Briguori C, Bruch L, Cruden N, Den Hartog AW, Garot P, Godin M, Hildick-Smith D, Johnson T, Ladwiniec A, Linke A, Maart CA, Mashayekhi K, Meier P, Meunier L, Morgan K, O'Kane P, Puymirat E, Rissanen TT, Sabaté M, Schmitz T, Toth GG, Trevelyan J, Wanczura P, Marcus W, Wykrzykowska JJ, Urban P, Eccleshall S, SELUTION DeNovo Investigators

doi: 10.1161/CIRCULATIONAHA.126.079033

Further Publications

Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT Trial

Circ Cardiovasc Interv

Chevalier B, Cao D, Smits PC, Brunel P, Frigoli E, Heg D, Higuchi Y, Kauer F, Landi A, Lopes RD, Mainar V, Mamas MA, Mateev H, McDonald J, McFadden EP, Mulassary A, Munir S, Polad J, Reimers B, Sardella G, Ungi I, von Birgerlen C, Weidinger F, Paradies V, Valgimigli M, MASTER DAPT Investigators

doi: 10.1161/CIRCINTERVENTIONS.125.016222

Heart, Artery and Coronary DiseasesTherapy and Intervention

Long-term outcomes after percutaneous coronary intervention of in-stent restenosis in patients presenting with acute and chronic coronary syndrome

Clin Res Cardiol

Kuna C, Mayer M, Bradaric C, Koch T, Presch A, Voll F, Kufner S, Ibrahim T, Schunkert H, Laugwitz KL, Cassese S, Kastrati A, Wiebe J

doi: 10.1007/s00392-026-02989-1

Myocardial Infarction

Clinical Outcomes of Complete Revascularization in Acute Myocardial Infarction Patients With High Bleeding Risk and Multivessel Disease

J Am Heart Assoc

Kim O, Joh HS, Kim HK, Kim JH, Hong YJ, Ahn Y, Jeong MH, Hur SH, Kim DI, Chang K, Park HS, Bae JW, Jeong JO, Park YH, Yun KH, Yoon CH, Kim Y, Hwang JY, Kim HS, Kwon W, Shin D, Choi KH, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Gwon HC, Lee SH, Lee JM, KAMIR Investigators

doi: 10.1161/JAHA.125.042507

Myocardial Infarction

Comparison of the European Society of Cardiology 0/1-Hour and High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome 0/2-or-0/3-Hour Algorithms for Rapid Myocardial Infarction Diagnosis: A Prospective Multicenter Study

J Am Coll Cardiol

Glaeser J, Lopez-Ayala P, Kellner C, Boeddinghaus J, Nestelberger T, Koechlin L, Sörensen NA, Haller PM, Bima P, Crisanti L, Spagnuolo CC, Strebel I, Hure G, Sieber S, Rubini Gimenez M, Wildi K, Wussler D, Miro O, Martin-Sanchez FJ, Keller DI, Christ M, Twerenbold R, Mahfoud F, Neumann J, Mueller C, APACE and BACC Investigators

doi: 10.1016/j.jacc.2025.12.056

Heart, Artery and Coronary Diseases

Effects of Acute Exercise and 12-Week High-Intensity Interval Training on Inflammatory Biomarkers in Stable Coronary Artery Disease: A Randomized Controlled Trial

J Am Heart Assoc

Kristiansen J, Kristensen SD, Hvas AM, Ellingsgaard H, Mohr M, Grove EL, Sjúrðarson T

doi: 10.1161/JAHA.125.042256

Cardiovascular Risk and Diseases

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial

JAMA Cardiol

Mulvagh SL, Inzucchi SE, Marx N, Poulter NR, Deanfield JE, Pop-Busui R, Emerson SS, Mann JFE, Engelmann MDM, Hovingh GK, Mandavya K, Davicevic-Elez Z, Jeppesen OK, Lorenzatti A, Oguz A, Mankovsky B, Deerochanawong C, Gorgojo-Martinez JJ, Ji L, Bain SC, McGuire DK, Buse JB, SOUL Study Group

doi: 10.1001/jamacardio.2026.0245

Heart, Artery and Coronary Diseases

Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial

Eur Heart J

Dillinger JG, Pezel T, Batias L, Angoulvant D, Goralski M, Ferrari E, Cayla G, Silvain J, Gilard M, Lemesle G, Souteyrand G, Lim P, Roubille F, Georges JL, Bal Dit Sollier C, Petroni T, Morel O, Delarche N, Elbaz M, Puymirat E, Toupin S, Montalescot G, Drouet L, Vicaut E, Henry P, ANDAMAN Investigators of the ACTION Study Group

doi: 10.1093/eurheartj/ehaf680